Literature DB >> 18458713

Interferences in immunoassay.

Jill Tate1, Greg Ward.   

Abstract

Substances that alter the measurable concentration of the analyte or alter antibody binding can potentially result in immunoassay interference. Interfering, endogenous substances that are natural, polyreactive antibodies or autoantibodies (heterophiles), or human anti-animal antibodies together with other unsuspected binding proteins that are unique to the individual, can interfere with the reaction between analyte and reagent antibodies in immunoassay. Lipaemia, cross-reactivity, and exogenous interferences due to pre-analytical variation, matrix and equipment reaction also affect immunoassay. Interfering substances may lead to falsely elevated or falsely low analyte concentration in one or more assay systems depending on the site of the interference in the reaction and possibly result in discordant results for other analytes. The prevalence of interference is generally low in assays containing blocking agents that neutralise or inhibit the interference but is often higher in new, untested immunoassays. A wide range of analytes measured by immunoassay including hormones, tumour markers, drugs, cardiac troponin and microbial serology may be affected. Interference in immunoassay may lead to the misinterpretation of a patient's results by the laboratory and the wrong course of treatment being given by the physician. Laboratories should put processes in place to detect, test and report suspected interferences. It is equally important that physicians communicate any clinical suspicion of discordance between the clinical and the laboratory data to the laboratory. The detection of interference may require the use of an alternate assay or additional measurements, before and after treatment with additional blocking reagent, or following dilution of the sample in non-immune serum. It is imperative that laboratories inform physicians of the follow-up procedure and report on the presence of any interference. The establishment of on-going laboratory-physician contact is essential to the continuing awareness of wrong patient results due to interference.

Entities:  

Year:  2004        PMID: 18458713      PMCID: PMC1904417     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  95 in total

Review 1.  Interference in immunoassay.

Authors:  C Selby
Journal:  Ann Clin Biochem       Date:  1999-11       Impact factor: 2.057

2.  Performance of today's cardiac troponin assays and tomorrow's.

Authors:  Mauro Panteghini
Journal:  Clin Chem       Date:  2002-06       Impact factor: 8.327

Review 3.  Interference in immunoassay is an underestimated problem.

Authors:  A A A Ismail; P L Walker; M L Cawood; J H Barth
Journal:  Ann Clin Biochem       Date:  2002-07       Impact factor: 2.057

Review 4.  Endogenous interference in immunoassays in clinical chemistry. A review.

Authors:  T H Weber; K I Käpyaho; P Tanner
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

5.  False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma.

Authors:  L A Cole; K M Rinne; S Shahabi; A Omrani
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

6.  Heterophilic antibodies remain a problem for the immunoassay laboratory.

Authors:  G Ward; L McKinnon; T Badrick; P E Hickman
Journal:  Am J Clin Pathol       Date:  1997-10       Impact factor: 2.493

7.  Incidence and mechanism of spurious increase in serum thyrotropin.

Authors:  P J Howanitz; J H Howanitz; H V Lamberson; K M Ennis
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

8.  Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?

Authors:  W Steimer
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

9.  A new interference in some digoxin assays: anti-murine heterophilic antibodies.

Authors:  C Liendo; J K Ghali; S W Graves
Journal:  Clin Pharmacol Ther       Date:  1996-11       Impact factor: 6.875

10.  Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.

Authors:  Carol M Preissner; Dennis J O'Kane; Ravinder J Singh; John C Morris; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

View more
  122 in total

1.  Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG.

Authors:  Xiangdan Wang; Valerie Quarmby; Carl Ng; Anan Chuntharapai; Theresa Shek; Charles Eigenbrot; Robert F Kelley; Steven Shia; Krista McCutcheon; John Lowe; Cecilia Leddy; Kyle Coachman; Gary Cain; Felix Chu; Isidro Hotzel; Mauricio Maia; Eric Wakshull; Jihong Yang
Journal:  MAbs       Date:  2013-04-29       Impact factor: 5.857

2.  Large molecule specific assay operation: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Authors:  Lauren Stevenson; Marian Kelley; Boris Gorovits; Clare Kingsley; Heather Myler; Karolina Osterlund; Arumugam Muruganandam; Yoshiyuki Minamide; Mario Dominguez
Journal:  AAPS J       Date:  2013-11-16       Impact factor: 4.009

3.  The Brief Case: False-Positive Rapid Malaria Antigen Test Result in a Returned Traveler.

Authors:  Kristle L Haberichter; Paul C Johnson; Paul J Chittick; Peter Millward; Barbara Robinson-Dunn; Bobby L Boyanton
Journal:  J Clin Microbiol       Date:  2017-08       Impact factor: 5.948

4.  Variability among TSH Measurements Can Be Reduced by Combining a Glycoengineered Calibrator to Epitope-Defined Immunoassays.

Authors:  Sandrine Donadio-Andréi; Karim Chikh; Christine Heuclin; Elisabetta Kuczewski; Anne Charrié; Anne-Sophie Gauchez; Catherine Ronin
Journal:  Eur Thyroid J       Date:  2016-12-22

Review 5.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

6.  Coexistence of thyroid-stimulating hormone-secreting pituitary adenoma and graves' hyperthyroidism.

Authors:  Mahdi Kamoun; Michèle d'Herbomez; Christine Lemaire; Armelle Fayard; Rachel Desailloud; Damien Huglo; Jean-Louis Wemeau
Journal:  Eur Thyroid J       Date:  2013-11-20

Review 7.  Wound samples: moving towards a standardised method of collection and analysis.

Authors:  Sarah Ramsay; Linda Cowan; Jeffrey M Davidson; Lillian Nanney; Gregory Schultz
Journal:  Int Wound J       Date:  2015-01-11       Impact factor: 3.315

8.  Silk-based blood stabilization for diagnostics.

Authors:  Jonathan A Kluge; Adrian B Li; Brooke T Kahn; Dominique S Michaud; Fiorenzo G Omenetto; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

9.  Effects of serum and plasma matrices on multiplex immunoassays.

Authors:  Yael Rosenberg-Hasson; Leo Hansmann; Michaela Liedtke; Iris Herschmann; Holden T Maecker
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

10.  Interference testing.

Authors:  Goce Dimeski
Journal:  Clin Biochem Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.